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Practical ImplicationsOur identification of the dominated routes, that is the close contact route (large droplet) for influenza, the fomite route for norovirus, and all 3 routes for SARS CoV, suggested the relative importance of different environment intervention for different infectious diseases in air cabins and probably also in other indoor environments. For minimizing in‐flight fomite transmission, the aisle seatbacks and toilets should be cleaned and disinfected effectively.

1. INTRODUCTION {#ina12445-sec-0002}
===============

Knowledge about the relative importance of different transmission route(s) is fundamental to developing effective intervention strategies for infectious respiratory and enteric diseases in indoor environments. Epidemiological analysis together with in‐depth environmental investigations often provides useful insights,[1](#ina12445-bib-0001){ref-type="ref"} and meta‐analysis may also be carried out for a particular disease. In this study, we proposed an alternative comparative analysis approach in which we studied outbreaks of different diseases in the same environment using the same approach, by examining differences in the spatial infection patterns. This approach could partly overcome the limitation of traditional individual outbreak analysis that outbreak cannot be repeatedly observed, because the comparative analysis of different diseases in the same environment is like that one disease happened several times. Our hypothesis is that the different transmission routes of infection lead to different spatial patterns of secondary cases. For example, close contact transmission always happens with 1‐2 m of the source, which means that secondary cases infected via close contact route would be close to the index case(s). The airborne transmission may occur over long distance, and the secondary cases infected via airborne route would distribute uniformly in a space when the air is fully mixed.

Aircraft cabins were selected as the context for our study. The more or less fixed seating arrangement in aircraft cabins permits a spatial pattern of the secondary cases to be identified in some outbreaks. The temporal and spatial variation of the environment in aircraft cabins is also not as great as it is in other environmental spaces. Understanding transmission routes in aircraft cabins is itself an important issue for not only onboard intervention, but also the worldwide infection transmission since air travel had been proved to be important in the 2003 severe acute respiratory syndrome (SARS) outbreak and 2009 influenza A H1N1 outbreak.[2](#ina12445-bib-0002){ref-type="ref"} Confined space, limited ventilation, recirculated air, and/or prolonged exposure times, which are common in air travel, are demonstrated risk factors for the transmission of infectious diseases,[3](#ina12445-bib-0003){ref-type="ref"} such as tuberculosis, influenza, common cold, SARS, and gastroenteritis.

Our study focused on 3 viruses: influenza A H1N1, SARS coronavirus (CoV), and norovirus. The 1918 influenza pandemic killed 20‐40 million people, and influenza can still kill thousands each year.[4](#ina12445-bib-0004){ref-type="ref"} SARS CoV outbreaks in 2003 caused thousands of deaths around the world. Norovirus is the leading cause of nonbacterial gastroenteritis in humans.[5](#ina12445-bib-0005){ref-type="ref"}, [6](#ina12445-bib-0006){ref-type="ref"} The 3 major possible routes in aircraft cabins are close contact, airborne, and fomite.[7](#ina12445-bib-0007){ref-type="ref"}

In this study, a mathematical model was built to study the in‐flight infection transmission process, based on the studies by Atkinson and Wein[8](#ina12445-bib-0008){ref-type="ref"} and Nicas and Jones.[9](#ina12445-bib-0009){ref-type="ref"} This technique enables detailed physical and biological processes to be modeled and the impact of environmental parameters to be easily integrated. We compared the simulated relative importance of different transmission routes in 3 in‐flight outbreaks with the reported spatial distribution of the secondary cases.

2. DATA AND METHODS {#ina12445-sec-0003}
===================

2.1. Three chosen outbreaks {#ina12445-sec-0004}
---------------------------

We performed a literature search for in‐flight outbreaks of influenza A H1N1, SARS CoV, and norovirus in Appendix [S1](#ina12445-sup-0001){ref-type="supplementary-material"}. All 3 chosen outbreaks occurred in Boeing 737 aircraft cabins with flight duration 2.5 or 3 hours. The main criteria for identifying suitable outbreaks include the availability of detailed seating information for both the infected and noninfected, airplane type and flight duration. Figure [1](#ina12445-fig-0001){ref-type="fig"} illustrates the detailed spatial distribution of the secondary cases in the chosen outbreaks.

![Spatial distribution for 3 in‐flight infection outbreaks, (A) norovirus,[26](#ina12445-bib-0026){ref-type="ref"} (B) SARS CoV,[27](#ina12445-bib-0027){ref-type="ref"} and (C) influenza A H1N1[28](#ina12445-bib-0028){ref-type="ref"}](INA-28-394-g001){#ina12445-fig-0001}

2.2. Multiroute disease transmission model {#ina12445-sec-0005}
------------------------------------------

The definitions for the relevant transmission routes (Figure [2](#ina12445-fig-0002){ref-type="fig"}) in our multiroute model are as follows.

![Illustration of different transmission routes considered in this study. Note that all sizes of droplets are involved in the fomite route](INA-28-394-g002){#ina12445-fig-0002}

The airborne route refers to direct inhalation of an infectious agent through small droplet nuclei, that is, the residue of large droplets containing microorganisms that have evaporated to an aerodynamic diameter of less than 10 microns (termed respirable).[9](#ina12445-bib-0009){ref-type="ref"} These respirable droplets can deposit in the respiratory tract.

Close contact route includes direct contact and large droplet transmission. Direct contact refers to infection through person‐to‐person contact with the index source passenger, such as handshaking. We assume there is no body‐to‐body contact between index source passenger(s) and other passengers during the flight. We only consider large droplet transmission in the model, which refers to the *inhalation* of the virus carried in respirable airborne particles with a diameter between 10 and 100 microns (termed inspirable),[9](#ina12445-bib-0009){ref-type="ref"} and the *droplet spray* of large droplets (\>100 microns in diameter) onto facial target membranes.

The fomite route refers to infection by touching objects or surfaces that have earlier been contaminated by hands or by direct deposition of infectious pathogens from the index source passenger, which is also sometimes termed indirect contact route.

### 2.2.1. Virus‐containing droplets generation {#ina12445-sec-0006}

For *respiratory disease*, coughing is used as surrogate to model the virus‐containing droplets from all respiratory activities such as breathing, talking, and sneezing, as the size distribution of the droplets from coughing, talking, and sneezing is similar, and the amount of droplets generated due to breathing is negligible. Assume that cough frequency for infector is *f* ~*c*~ per hour and that one cough can produce *N* ~*c*~ droplets with the size distribution $F_{c}\left( r_{0} \right)$. Then, the generation rate (number/h) of droplets with radius *r* ~0~ (μm) from individual *i* is given by: $G_{i}\left( r_{0} \right) = f_{c}N_{c}F_{c}\left( r_{0} \right)$.

For *enteric disease*, such as norovirus, virus‐containing droplets are emitted from the infector in vomit and/or diarrhea. A study by simulated vomiting device showed that the volume of the aerosolized droplets ranged from 0.004 to 21 mL, with a mean value of 0.4 mL.[10](#ina12445-bib-0010){ref-type="ref"} To the best of our knowledge, there is no study on the size distribution of the droplets from vomit, and we assume that these droplets have same size distribution as those from coughing.

### 2.2.2. Fates and concentration of virus‐containing droplets in air cabin {#ina12445-sec-0007}

For *respirable droplets* with aerodynamic diameter of less than 10 microns, they could move a long distance with the airflow and distribute in the air in cabin with volume *V* (m^3^). Liu et al[11](#ina12445-bib-0011){ref-type="ref"} studied respirable droplet concentration at different distance away from the source and found that respirable droplet concentration is uniform everywhere except within 1 m of the source. A concentration ratio $\varepsilon_{c}\left( s_{i} \right) = C_{l}^{i}\left( {r,t} \right)/C_{e}\left( {r,t} \right)$ was defined, where $C_{l}^{i}\left( {r,t} \right)$ was the number concentration (number/m^3^) of the airborne droplets in the inhaled air of individual *i* with radius *r* at time *t*; $C_{e}\left( {r,t} \right)$ was the droplet nuclei concentration (number/m^3^) out of 1 meter of the index case. A simple model adapted from Liu et al[11](#ina12445-bib-0011){ref-type="ref"} was used to describe the concentration ratio at distance *s* (m) away from the source, in Equation [(1)](#ina12445-disp-0001){ref-type="disp-formula"}:$$\varepsilon_{c}{(s)} = \left\{ \begin{matrix}
{- 6s + 7,\; s < 1} \\
{1,\; s \geq 1} \\
\end{matrix} \right.$$

For *inspirable droplets* with a diameter between 10 and 100 microns, we assumed that the maximum horizontal distance they could move was 2 m because of gravity and the relatively high deposition rate on environmental surfaces. They distributed within 2 m of the source, and the volume of this space was denoted to be *V* ~2~ (m^3^).

A rapid death rate of pathogens atomized into air had been observed,[12](#ina12445-bib-0012){ref-type="ref"}, [13](#ina12445-bib-0013){ref-type="ref"} and evaporation of droplets was believed to play an important role.[14](#ina12445-bib-0014){ref-type="ref"} Xie et al[15](#ina12445-bib-0015){ref-type="ref"} found that there was a fast viability decline stage when the droplets completely evaporated, when viability decreased to about 25% and then slowly declined. Here, the survival ratio due to evaporation was defined as $\varepsilon_{e}\left( {r_{0},s} \right) = L\left( {r_{0},t} \right)/L\left( {r_{0},0} \right)$ $$\varepsilon_{e}\left( {r_{0},s} \right) = \left\{ \begin{matrix}
{1,\quad if\; T_{e}\left( r_{0} \right) > T_{m}\left( s \right)\;} \\
{0.25,\quad if\; T_{e}\left( r_{0} \right) < T_{m}\left( s \right)\;} \\
\end{matrix} \right.$$where $L\left( {r_{0},t} \right)$ is the concentration of viable viruses (TCID~50~/mL or genome copies/mL) in droplets with initial radius *r* ~0~ (μm) at the time *t* (s) after being exhaled; $T_{e}\left( r_{0} \right)$ is the evaporation time (s) for the droplets with radius*r* ~0~ (μm); $T_{m}\left( s \right)$ is the traveling time (s) for the exhaled droplets from the source to reach a susceptible individual a distance *s* (m) away. Xie et al[16](#ina12445-bib-0016){ref-type="ref"} studied the evaporation time of droplets with different diameters, and a fitting function $T_{e}\left( r_{0} \right) = \beta_{e}{r_{0}}^{2}$ was used in this study, where $\;\beta_{e} = 7 \times 10^{- 4}$ s/μm^2^. $T_{m}\left( s \right) = s/V_{m}$, where *V* ~*m*~ is droplet speed (m/s) and *s* is the distance (m) away from the index case. The advective flow velocity toward the cabin aft is about 0.1 m/s.[17](#ina12445-bib-0017){ref-type="ref"} And according to one field experiment in the first class cabin, 72% of the test points in the cabin had a velocity lower than 0.1 m/s, so in this study, we assume that the average airflow velocity in the air cabin is 0.1 m/s and *V* ~*m*~ is also 0.1 m/s.[18](#ina12445-bib-0018){ref-type="ref"}

Assume there is no resuspension of droplets from environmental surfaces into the air. In the air cabin, on the one hand, viable virus is generated from index case(s) at rate$\sum\limits_{i = 1}^{N}I_{i}G_{i}\left( r_{0} \right)L\left( {r_{0},0} \right)$, where *I* ~*i*~ is the index of individual *i* (if individual *i* is the infector, *I* ~*i*~ = 1, else *I* ~*i*~ = 0); The contribution of viable viruses from the 50% return air is ignored as the HEPA filter efficiency is very high, and the minimum efficiency can be as high as 99.97%.[19](#ina12445-bib-0019){ref-type="ref"} On the other hand, the viable virus‐containing droplets are removed from the cabin by ventilation system at rate *q* and *q *=* *25/h,[20](#ina12445-bib-0020){ref-type="ref"} natural inactivation at rate *b* ~*a*~ (/h), and deposition on environmental surfaces at rate *k* ~*d*~ *r* ^2^ (/h).

For *respirable droplets*, which are distributed in the air cabin with volume *V* (m^3^), we have$$\frac{d{(\int_{0}^{V}\varepsilon_{c}\left( s \right)C_{e}\left( r_{0} \right)L\left( {r_{0},t} \right)dv)}}{\mathit{dt}\int = \sum\limits_{i = 1}^{N}I_{i}G_{i}\left( r_{0} \right)L\left( {r_{0},0} \right) - {({q + b_{a} + k_{d}r^{2}})}VC_{e}\left( {r,t} \right)L\left( {r_{0},t} \right)}$$

For *inspirable droplets*, which are distributed in the space of volume *V* ~2~ (m^3^) within 2 m of the index case, similarly, we have$$\begin{array}{cl}
 & {d\left( {\int\limits_{0}^{V_{2}}\varepsilon_{c}\left( s \right)C_{b}\left( r_{0} \right)L\left( {r_{0},t} \right)dv} \right)/dt} \\
 & {= G_{i}\left( r_{0} \right)L\left( {r_{0},0} \right) - \left( {q + b_{a} + k_{d}r^{2}} \right)V_{2}C_{b}\left( {r,t} \right)L\left( {r_{0},t} \right)} \\
\end{array}$$where $C_{b}\left( r \right)\;$is the droplet concentration (number/m^3^) at the boundary of the space within 2 m of the index case.

For *influenza and SARS*, viable virus‐containing droplets are emitted continuously through coughing, and if we assumed that the concentration of the virus‐containing droplets would reach a steady state, then we have$$C_{e}\left( {r,t} \right)L\left( {r_{0},t} \right) = \sum\limits_{i = 1}^{N}I_{i}G_{i}\left( r_{0} \right)L\left( {r_{0},0} \right)\;/\left( {\left( {q + b_{a} + k_{d}r^{2}} \right)V} \right)$$and$$C_{b}\left( {r,t} \right)L\left( {r_{0},t} \right) = G_{i}\left( r_{0} \right)L\left( {r_{0},0} \right)/\left( {\left( {q + b_{a} + k_{d}r^{2}} \right)V_{2}} \right)$$

For *norovirus*, virus‐containing droplets are emitted from the infector in vomit and/or diarrhea, which are rarer than coughs, so in the norovirus outbreak it is not reasonable to assume that the airborne virus‐containing droplet concentration from vomit or diarrhea will achieve a steady state. After each vomiting or diarrheal episode, we therefore assumed the droplets would quickly and uniformly distribute in the air, which was set as the initial condition. The concentration of the viable norovirus‐containing airborne droplets ($C_{n}\left( {r,t} \right)$, number/m^3^) in the air cabin could be calculated according to the following equation:$$V\frac{d\left( {C_{n}\left( {r,t} \right)L\left( {r_{0},t} \right)} \right)}{dt} = - \left( {q + b_{a} + k_{d}r^{2}} \right)VC_{n}\left( {r,t} \right)L\left( {r_{0},t} \right)$$ $$C_{n}\left( {r,t_{0}} \right) = N_{v}PrF_{c}\left( r_{0} \right)/V,\quad{for}\, r < 5\,{\mu m}$$where *t* ~0~ is the time when the vomit or diarrhea accident occurs; *N* ~*v*~ is the number of aerosolized droplets generated during each vomit; *Pr* is the assumed percentage of respirable droplets emitted into the air, so if patient(s) vomit on the ground, *Pr* = 1, and if they vomit into sickbags, *Pr* = .1. Predicted results with different percentages of airborne droplets emitted from sickbags are compared in Appendix [S3](#ina12445-sup-0001){ref-type="supplementary-material"}. The solution of Equation [(7)](#ina12445-disp-0008){ref-type="disp-formula"} was$$C_{n}\left( {r,t} \right)L\left( {r_{0},t} \right) = C_{n}\left( {r,t_{0}} \right)e^{- {({q + b_{a} + k_{d}r^{2}})}{({t - t_{0}})}}$$

The exposure through each route was modeled separately, and then the dose‐response model was used to assess an integrated risk.

### 2.2.3. Exposure via airborne route {#ina12445-sec-0008}

The dose to individual *i* via the airborne route in the lower and upper respiratory tracts is denoted as $D_{\mathit{al}}^{i}$ and $D_{\mathit{au}}^{i}$ (TCID~50~ or genome copies), and for a flight duration *T*, they can estimated as follows:$$D_{\mathit{al}}^{i} = \int\limits_{o}^{T}\int\limits_{0}^{r_{a}}C_{l}^{i}\left( {r,t} \right){p\delta}_{l}\left( r \right)t\frac{4}{3}\pi r_{0}^{3}L\left( {r_{0},t} \right)drdt$$ $$D_{\mathit{au}}^{i} = \int\limits_{o}^{T}\int\limits_{0}^{r_{a}}C_{l}^{i}\left( {r,t} \right){p\delta}_{u}\left( r \right)t\frac{4}{3}\pi r_{0}^{3}L\left( {r_{0},t} \right)drdt$$where *r* ~*a*~ is the largest radius for airborne droplets and *r* ~*a*~ = 5 μm[9](#ina12445-bib-0009){ref-type="ref"}; *p* is the pulmonary ventilation rate and *p *=* *.48 m^3^/h[21](#ina12445-bib-0021){ref-type="ref"}; *r* ~0~ is the droplets' initial radius; and *r* is the final radius after complete evaporation. Here, we assume that *r* = *r* ~0~/3[10](#ina12445-bib-0010){ref-type="ref"}; ${}_{l}\left( r \right)$ and ${}_{u}\left( r \right)$ are the deposition fraction of droplets with radius *r* in the lower and upper respiratory tracts, respectively. The model from ICRP was used in this study.[22](#ina12445-bib-0022){ref-type="ref"}

### 2.2.4. Exposure via close contact route {#ina12445-sec-0009}

Transmission by close contact refers to either inhalation of the virus carried in airborne particles with a diameter between 10 and 100 microns, or the spray of large droplets on the susceptible individuals' mucous membranes.

For norovirus transmission, it is difficult for the "large" droplets generated from vomiting to move to the inhale air of the seated susceptible passengers, which is always more than one meter above the ground, because of the high downward velocity, gravity, and the relatively high deposition rate. Therefore, the close contact route was not considered in the norovirus transmission.

Then the dose via inhalation of inspirable droplets in upper respiratory tract ($D_{\mathit{cr}}^{i}$ (TCID~50~ or genome copies)) was$$D_{\mathit{cr}}^{i} = \int\limits_{o}^{T}\int\limits_{r_{a}}^{r_{b}}\varepsilon_{c}\left( s_{i} \right)C_{b}\left( {r,t} \right){pt\delta{}_{u}}\left( r \right)\frac{4}{3}\pi r_{0}^{3}L\left( {r_{0},t} \right)drdt$$

where *r* ~*b*~ was radius of the maximum inspirable droplets and *r* ~*b*~ = 50 μm.[9](#ina12445-bib-0009){ref-type="ref"}

For the spray of large droplets on mucous membranes, because of the seating arrangement we assumed that there was no face‐to‐face droplet spray on susceptible individual mucous membranes. In this study a simple model was used, in which it was assumed that the number of droplets deposited on one surface was proportional to its area. Denote the total surface area of the space within 2 m of the index case as $A_{V_{2}}$ (m^2^) and the area of mucous membrane of one person as *A* ~*m*~ (m^2^). In the space within 2 m of the index case, there are 30 seats (5 rows and 6 seats per row) with area 1 m^2^ for each, and the human body surface area is about 1.75 m^2^, and there are overlaps between body and seat surfaces when sitting, so an estimated area 2 m^2^ is used for each seat and the passengers sitting on it. The floor area is 4 m × 3.2 m = 12.8 m^2^, so an estimated value for $A_{V_{2}} = 30 \times 2{}m^{2} + 12.8\; m^{2}$= 72.8 m^2^, and $A_{m} = 0.001\; m^{2}$ is used in this study. The dose via the close contact route due to deposition on mucous membrane is $$D_{\mathit{cm}}^{i} = \int\limits_{o}^{T}\int\limits_{r_{a}}^{\infty}\frac{A_{m}}{A_{V_{2}}}C_{c}^{i}\left( r \right)kr^{2}V_{2}t\frac{4}{3}\pi r_{0}^{3}L\left( {r_{0},t} \right)drdt$$

### 2.2.5. Exposure via fomite route {#ina12445-sec-0010}

A Markov Chain was built to model the fomite route infection transmission. Define a matrix $Ps = \left( {ps\left( k \right)} \right)_{N_{s} \times N_{p}}$, which shows surface‐touching behavior. If on time step *k*, individual *i* touched surface *j*, $ps_{j,i}\left( k \right)$ = 1, else $ps_{j,i}\left( k \right) = 0$. Denote the virus concentration on individual *i* hand and environmental surface *j* at time *k* by $C_{h}^{i}\left( k \right)$ and $C_{s}^{j}\left( k \right)$ (TCID~50~ or genome copies/m^2^), respectively. In the next time step *k* + 1 after time *ΔT*, the number of infectious pathogens on the hand contact area on the environmental surfaces *j* is$$\begin{aligned}
{C_{s}^{j}\left( {k + 1} \right)} & {= \left( {C_{s}^{j}\left( k \right) + \frac{\sum_{i = 1}^{N_{p}}{(C_{h}^{i}\left( k \right)A_{\mathit{hs}}\tau_{\mathit{hs}} - C_{s}^{j}\left( k \right)A_{\mathit{hs}}\tau_{\mathit{sh}})}ps_{i,j}\left( k \right)}{A_{s}}} \right)e^{- b_{s} \times \Delta T}} \\
\end{aligned}$$where *A* ~*hs*~ is the connection area (m^2^) between hand and the environmental surface during contact, *A* ~*s*~ is the area (m^2^) of surface *j*. We estimated *A* ~*hs*~ = 0.0042 m^2^ [23](#ina12445-bib-0023){ref-type="ref"}; τ~*hs*~ is the pathogen transfer efficiency from hand to environmental surface; τ~*sh*~ is the pathogen transfer efficiency from surface to hand; *b* ~*s*~ is the first‐order (exponential) inactivation rate (/h) of pathogens on environmental surfaces.

Denote $pm_{i}\left( k \right)$ as the mucous membrane‐touching behavior of individual *i*; that is, if at time interval *k*, individual *i* touches his/her mucous membranes, $pm_{i}\left( k \right) = 1$, else $pm_{i}\left( k \right) = 0$. It is assumed that a touch on the mucous membranes involves only one fingertip of the same hand that touches the contaminated environmental surfaces, and this process is a one‐way transmission, that is, from hand to mucous membranes.

Then, the virus concentration on individual *i* hand at time *k* + 1 is$$\begin{array}{r}
{C_{h}^{i}\left( {k + 1} \right) = \left( {C_{h}^{i}\left( k \right) - \frac{\sum_{i = 1}^{N_{p}}{(C_{h}^{i}\left( k \right)A_{\mathit{hs}}\tau_{\mathit{hs}} - C_{s}^{j}\left( k \right)A_{\mathit{hs}}\tau_{\mathit{sh}})}ps_{i,j}\left( k \right)}{A_{h}} - \frac{\; pm_{i}\left( k \right)A_{h}^{m}\tau_{\mathit{hm}}C_{h}^{i}\left( k \right)}{A_{h}}} \right)\; e^{- b_{h} \times \Delta T}} \\
\end{array}$$where *A* ~*h*~ is the hand palm area (m^2^), which was estimated to be 0.0203 m^2^ [24](#ina12445-bib-0024){ref-type="ref"}; *b* ~*h*~ is the pathogens' first‐order inactivation rate (/h) on hands; τ~*hm*~ is the virus transmission efficiency from hand to mucous membranes; $A_{h}^{m}$ is the hand‐to‐mucous membrane connection area (m^2^); and $A_{h}^{m}$ is assumed to be 0.0001 m^2^.

Given the initial condition (*k* = 0) of the virus concentration on all of the environmental surfaces, then the virus concentration in each time interval can be calculated. The total dose to individual *i* via the fomite route is$$D_{\mathit{fm}}^{i} = \sum\limits_{k = 1}^{\; N_{t}}\; Pm_{i}\left( k \right)A_{h}^{m}\tau_{\mathit{hm}}C_{h}^{i}\left( k \right)$$where *N* ~*t*~ is the total time intervals and $N_{t} = \frac{T}{\Delta T}$, *T* is the flight duration, and ⌊$\frac{T}{\Delta T}$⌋ is the floor function.

### 2.2.6. Infection risk assessment {#ina12445-sec-0011}

The negative exponential dose‐response model was used to estimate the infection risk, which implies that a single particle can start an infection, all single particles are independent of each other. The infection risk of individual *i* during the flight can be calculated according to the following equation$$P_{i} = 1 - e^{\lbrack{- {({\eta_{l}D_{\mathit{al}}^{i} + \eta_{u}D_{\mathit{au}}^{i}})} - {({\eta_{u}D_{\mathit{cr}}^{i} + \eta_{m}D_{\mathit{cm}}^{i}})} - \eta_{m}D_{\mathit{fm}}^{i}}\rbrack}$$where η~*l*~ η~*l*~, η~*u*~, and η~*m*~ are the dose‐response rates (/TCID~50~ or/genome copy) in lower/upper respiratory tracts and on mucous membranes, respectively. Here it is also assumed that η~*u*~ = η~*m*~.

2.3. Model parameterization {#ina12445-sec-0012}
---------------------------

Many parameters in the model are uncertain. For example, different viruses may have different infectivity, survivability, and shedding profiles. Even for the same virus, different populations may have different susceptibility. We use value from empirical literatures as well as our estimation for these parameters, and we also apply lower and upper parameter constraints for 7 categories of parameters that have been proved to be significantly correlated with the model reproductive number (see detail in Appendix [S2](#ina12445-sup-0001){ref-type="supplementary-material"}).[25](#ina12445-bib-0025){ref-type="ref"} The probability distribution of each parameter in these 7 categories is defined as follow: uniformly distributed from lower constraint to median value, and from median value to upper constraint, in addition, the mean value of the distribution is equal to the median value. As there was some randomness in the choice of the parameter values, for each case, the simulation was implemented with 400 replications, which are sufficient to generate statistical stability, as the difference between the simulated percentage contribution of each route with 400 replications and 800 replications was less than 3% (see detail in Appendix [S4](#ina12445-sup-0001){ref-type="supplementary-material"}).

Due to the large range of the virus shedding magnitude, there was a large range in the simulated number of infected passengers during flight in these 400 replications. In addition, during the 2.5‐ to 3‐hour flight, the virus shedding magnitude was relatively stable for each index case, as the virus concentration in the exhaled droplets was relatively stable during such a short period. Therefore, to quantitatively compare with the reported outbreak data, we narrowed the shedding magnitude value in each outbreak so that the simulated mean infection risk for all of the passengers in these 400 replications was close to the reported attack rate. In the influenza outbreak simulation, the virus shedding magnitude was set to between 1.8 × 10^12^ and 1.8 × 10^13^ TCID~50~/(mL·h) (the constraints for this parameter ranged from 1.8 × 10^9^ to 1.8 × 10^13^); in the SARS CoV outbreak, the virus shedding magnitude was set to between 1.8 × 10^12^ and 1.8 × 10^13^ mRNA copies/(mL·h) (the constraints for this parameter ranged from 1.8 × 10^9^ to 1.8 × 10^13^); in the norovirus outbreak, the virus shedding magnitude was set to between 2 × 10^14^ and 2 × 10^15^ genome copies/(mL·h) (the constraints for this parameter is from 3 × 10^13^ to 3 × 10^17^).

3. RESULTS {#ina12445-sec-0013}
==========

Figure [3](#ina12445-fig-0003){ref-type="fig"} provides the distribution of infected passengers and percentage contribution for each route in 3 outbreaks during these 400 replications, with the full range of the virus shedding magnitudes. In the influenza A H1N1 in‐flight transmission, in most cases, the number of passengers infected via the fomite route was much less than the number infected via the airborne and close contact routes, and more were infected via the close contact route than via the airborne route. In the SARS CoV in‐flight transmission, the numbers of passengers infected via all 3 routes had a similar order of magnitude. In the in‐flight norovirus outbreak, the close contact route was not considered, and in most cases, the number of passengers infected via the fomite route was much higher than the number infected via the airborne route.

![A, Distribution of simulated number of passengers infected during flight and B, percentage contribution of 3 transmission routes in 3 in‐flight outbreaks (with the full range of the virus shedding magnitudes). The box represents the interquartile range, and the horizontal line inside the box the median; vertical lines represent the maximum and minimum values without outliers](INA-28-394-g003){#ina12445-fig-0003}

Table [1](#ina12445-tbl-0001){ref-type="table"} summarizes the attack rate from reported outbreak data, and summarizes the predicted average infection risk and simulated number passenger infected (mean and 95% confidence interval \[CI\] of 400 replications) via 3 routes, respectively, in the 3 outbreaks with the tuned range of virus shedding magnitudes. Here, the attack rate is defined as the number of infected divided by the number of interviewed susceptible individuals. Under the chosen range of virus shedding magnitude, the simulated infection risks fit well with the reported attack rates in 3 outbreaks. Under this situation, the close contact route is suggested to contribute most in the in‐flight influenza A H1N1 transmission (contributes 70%, 95% CI: 67%‐72%, of the transmission, contribution of one route is defined as the number passenger infected via this route divided by the total number passenger infected via 3 routes together). In in‐flight SARS CoV transmission, airborne, close contact, and fomite route contribute 21% (95% CI: 19%‐23%), 29% (95% CI: 27%‐31%), and 50% (95% CI: 48%‐53%), respectively. The fomite route plays the dominant role (contributes 85%, 95% CI: 83%‐87%) in the in‐flight norovirus transmission.

###### 

Reported attack rate, predicted average infection risks, and number of passengers infected by 3 transmission routes, respectively (with the tuned range of the virus shedding magnitudes)

                     Reported attack rate   Simulated average infection risk (95% CI)   Simulated average number of passengers infected via 3 routes, respectively (95% CI)                    
  ------------------ ---------------------- ------------------------------------------- ------------------------------------------------------------------------------------- ---------------- -------------------
  Influenza A H1N1   4.3% (4/93)            3.8% (3.5%, 4.2%)                           1.9 (1.5, 2.2)                                                                        3.6 (3.2, 4.0)   0.04 (0.03, 0.05)
  SARS CoV           16.4% (18/110)         19.8% (18.3%, 21.3%)                        4.3 (3.6, 4.9)                                                                        4.8 (4.5, 5.1)   14.5 (13.1, 16.0)
  Norovirus          8.6% (6/70)            9.4% (8.4%, 10.4%)                          0.7 (0.5, 0.8)                                                                        0 (0, 0)         7.9 (7.0, 8.8)

John Wiley & Sons, Ltd

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

Different routes are expected to lead to different spatial distributions of secondary cases. For example, the close contact route causes a much higher infection risk for those sitting close to the ill passengers than those seated far away. The 2009 WHO guidance suggests contact tracing passengers seated within 2 rows of an infectious case of influenza during air travel.[29](#ina12445-bib-0029){ref-type="ref"}

Table [2](#ina12445-tbl-0002){ref-type="table"} lists the infection risk for passengers seated within 2 rows of the ill passenger(s) and for those seated farther away from both reported data and simulation results (mean and 95% CI of 400 replications with the narrowed virus shedding magnitude). Both the predicted infection risk and reported outbreak data show that in the influenza A H1N1 in‐flight outbreak, the infection risk for passengers sitting within 2 rows of the index case is statistically significantly higher than others, which coincides with our result that close contact route may be the most significant in the in‐flight influenza A H1N1 transmission.

###### 

Infection risks of passengers within 2 rows of the index case(s) and others from the simulation results and reported outbreak data, respectively (with the tuned range of the virus shedding magnitudes)

+------------------+--------------------------+----------------------------------------------------------------------------------+----------------------------------------+
|                  | Average infection risk   | Statistical properties from outbreak data[a](#ina12445-note-0001){ref-type="fn"} |                                        |
+==================+==========================+==================================================================================+========================================+
| Influenza A H1N1 | 14.0% (12.6%, 15.4%)     | 17.6% (3/17)                                                                     | *P *=* *.019                           |
|                  |                          |                                                                                  |                                        |
|                  | (2.0% \[1.7%, 2.3%\])    | (1.3% \[1/76\])                                                                  | RR:13.4                                |
|                  |                          |                                                                                  |                                        |
|                  |                          |                                                                                  | 95% CI:1.5‐121.2                       |
+------------------+--------------------------+----------------------------------------------------------------------------------+----------------------------------------+
| SARS CoV         | 41.2% (38.8%, 43.8%)     | 26.1% (6/23)[a](#ina12445-note-0001){ref-type="fn"}                              | *P *=* *.137 RR: 1.9 95% CI: 0.80‐4.50 |
|                  |                          |                                                                                  |                                        |
|                  | (14.7% \[13.3%, 16.0%\]) | 13.8% \[12/87\])                                                                 |                                        |
+------------------+--------------------------+----------------------------------------------------------------------------------+----------------------------------------+
| Norovirus        | Not applicable           | Not applicable                                                                   | Not applicable                         |
+------------------+--------------------------+----------------------------------------------------------------------------------+----------------------------------------+

1‐sided Chi‐squared test was used to test whether the passengers within 2 rows of the index case(s) had a statistically significant higher infection risk than others, and the *P* value (exact significance. \[1‐side\]), relative risk, and 95% CI are quoted. The *P* value \<.05 was considered significant.
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For the fomite route, Figure [4](#ina12445-fig-0004){ref-type="fig"} provides a typical seatback surface contamination network in a Boeing 737‐300 air cabin environment in one simulation. The surface contamination network in air cabin has a community structure. Different communities are connected by aisle seatback surfaces and toilets, because on the way to the toilet and back to their seats, the passenger may touch some aisle seatback surfaces. The aisle seat passengers are therefore more likely to have higher dose than nonaisle through the fomite route. Table [3](#ina12445-tbl-0003){ref-type="table"} compares the infection risk for the aisle and nonaisle seats from both the reported data and simulation results (mean and 95% CI of 400 replications with the narrowed virus shedding magnitude). According to the simulation results, the fomite route is suggested to play the dominant role in the norovirus in‐flight transmission in most cases. The report outbreak data also show that the aisle seat passengers have a significantly higher infection risk than others.

![Part of the surface contamination network in one sample simulation](INA-28-394-g004){#ina12445-fig-0004}

###### 

Reported and simulated infection risk for aisle and nonaisle seat passengers, respectively (with the tuned range of the virus shedding magnitudes)

+------------------+--------------------------+----------------------------------------------------------------------------------+-----------------------------------------+
|                  | Average infection risk   | Statistical properties from outbreak data[a](#ina12445-note-0002){ref-type="fn"} |                                         |
+==================+==========================+==================================================================================+=========================================+
| Influenza A H1N1 | 4.4% (4.0%, 4.9%)        | 6.1% (2/33)                                                                      | *P *=* *.446                            |
|                  |                          |                                                                                  |                                         |
|                  | (3.6% \[3.2%, 3.9%\])    | (3.3% \[2/60\])                                                                  | RR: 1.8                                 |
|                  |                          |                                                                                  |                                         |
|                  |                          |                                                                                  | 95% CI: 0.27‐12.3                       |
+------------------+--------------------------+----------------------------------------------------------------------------------+-----------------------------------------+
| SARS CoV         | 26.1% (24.1%, 28.0%)     | 15.8% (6/38 (16.7% \[12/72\])                                                    | *P *=* *.568 RR: 0.95 95% CI: 0.39‐2.33 |
|                  |                          |                                                                                  |                                         |
|                  | (16.7% \[15.4%, 17.9%\]) |                                                                                  |                                         |
+------------------+--------------------------+----------------------------------------------------------------------------------+-----------------------------------------+
| Norovirus        | 14.7% (13.1%, 16.3%)     | 20.8% (5/24)                                                                     | *P *=* *.022                            |
|                  |                          |                                                                                  |                                         |
|                  | (7.0% \[6.1%, 7.7%\])    | (2.2% \[1/46\])                                                                  | RR: 9.5                                 |
|                  |                          |                                                                                  |                                         |
|                  |                          |                                                                                  | 95% CI: 1.2‐77.4                        |
+------------------+--------------------------+----------------------------------------------------------------------------------+-----------------------------------------+

1‐sided Chi‐squared test was used to test whether the aisle passengers had a statistically significant higher infection risk than others, and the *P* value (exact significance. \[1‐side\]), relative risk, and 95% CI are quoted. The *P* value \<.05 was considered significant.
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4. DISCUSSION {#ina12445-sec-0014}
=============

In this study, we built a mathematical model to study the inflight transmission of different viruses, using a novel comparative analysis approach. The results suggested that the dominant transmission routes in air cabins are probably the close contact route for influenza, the fomite route for norovirus, and all 3 routes (airborne, close contact, and fomite routes) for SARS CoV. The dominant transmission routes vary for the 3 viruses, mainly depending on the pathogen‐specific parameters, such as the inactivation rate on human hands and environmental surfaces, the virus dose‐response rate, and the virus concentration. The outbreak data also affirmed our main hypothesis that the different transmission routes of infection led to different spatial patterns of secondary cases, so passengers within 2 rows of the index case in the influenza A H1N1 outbreak and passengers in aisle seats in the in‐flight norovirus outbreak had a significantly higher infection risk than others.

Our results should be interpreted at least with the following caveats. Firstly, many major assumptions were made for the model parameters, and some are judgment‐based and not well supported by evidence or data. For example, the SARS CoV dose‐response rate obtained in the mice experiments was applied to humans. In addition, the surface‐touching behavior, which is necessary when building a surface contamination network, is expected to vary very significantly, but we assumed that the same behavior is applied uniformly both in time and for individuals during the entire flight. The surface contamination network may be improved as more behavior data become available. Furthermore, the distribution and the constraints for each parameter set that were used might also not be realistic. These assumptions may challenge the conclusion that the fomite route is the dominant one for norovirus. Secondly, only one outbreak was available for our analysis for each virus. Generalization of findings due to one outbreak is questionable. Lastly, we have not considered the possibility of infection before and after the flight, such as during check‐in and in the lounge, which suggests that our analysis might have overestimated the overall in‐flight risk.

Our comparative analysis approach for multiple outbreaks and viruses differs from the traditional individual analysis of an outbreak.[1](#ina12445-bib-0001){ref-type="ref"} The same mechanisms of fomites (eg, surface or object contamination network) and bioaerosol transport (ie, close contact and airborne) are applied to all 3 pathogens in the cabin, with the only differences in the pathogen‐specific parameters (inactivation rate, surface transfer efficiency, etc.). In addition to previous theoretical work on relative importance of different transmission routes of influenza by Atkinson and Wein,[8](#ina12445-bib-0008){ref-type="ref"} Nicas and Jones,[9](#ina12445-bib-0009){ref-type="ref"} and Spicknall et al[25](#ina12445-bib-0025){ref-type="ref"} we simulated the real outbreaks and compared the simulation results with the outbreak data.

For influenza A H1N1, due to the high inactivation rate on environmental surfaces and hands, in most cases, the total infection risk via fomite route is much lower than that via airborne route and close contact route; this is consistent with the study by Atkinson and Wein[8](#ina12445-bib-0008){ref-type="ref"} in a household environment. The study by Teunis et al[30](#ina12445-bib-0030){ref-type="ref"} indicated that the infection probability of the droplet route (ie, close contact) and the aerosol route (ie, the airborne route) in a poorly ventilated room is approximately equal. But due to the high ventilation rate (25 per hour) and HEPA filter efficiency of ventilation system in the aircraft, and the close contact route is shown to be probably the most significant in in‐flight influenza transmission, the infection risk for passengers sitting close to the index case(s) is significantly high than others. In addition, a review study on human influenza transmission of Brankston et al[31](#ina12445-bib-0031){ref-type="ref"} concluded that transmission of influenza occurs at close range rather than over a long distance. Of the 5 in‐flight influenza A H1N1 outbreaks reviewed, with detailed distribution of the secondary cases included, 4 showed that the passenger sitting within the first 2 rows of the ill passenger(s) had a higher infection risk than others. The 2009 WHO guidance recommends the contact tracing of passengers seated within 2 rows of an infectious case of influenza during air travel.[29](#ina12445-bib-0029){ref-type="ref"} The air change rate and efficiency of the HEPA filter are relatively high in the aircraft ventilation system than other typical indoor environments, so that the airborne pathogens can be removed effectively. In most reported in‐flight influenza A H1N1 outbreaks, the attack rate is low (1%‐5%), but in the seasonal influenza A outbreak in March 1977, when the air conditioning system of a commercial airliner was shut down due to a malfunctioning engine, the attack rate reached 72%.[32](#ina12445-bib-0032){ref-type="ref"}

Compared with the influenza A H1N1 virus, the SARS CoV has a much lower inactivation rate on environmental surfaces and skin, which is probably why the fomite route is more important in SARS CoV transmission than that in influenza A H1N1 transmission. Our finding supports the combined findings of airborne transmission,[1](#ina12445-bib-0001){ref-type="ref"}, [33](#ina12445-bib-0033){ref-type="ref"} large droplet transmission,[34](#ina12445-bib-0034){ref-type="ref"} and fomite transmission for SARS CoV.[35](#ina12445-bib-0035){ref-type="ref"} As far as we are aware there are no data on the dose‐response rate of SARS CoV either on mucous membranes or in the respiratory tracts of humans. We assume that the dose‐response rate on human mucous membranes is the same as that on mice mucous membranes, and the dose‐response rate in the human respiratory tract is 1000 times that of mucous membranes (similar to the influenza A H1N1 data). We also performed the sensitivity analysis of the dose‐response rates, with different ratios of median dose‐response rate, that is (in lower respiratory tract)/(on mucous membranes) (see detail in Appendix [S5](#ina12445-sup-0001){ref-type="supplementary-material"}), and we found that all 3 routes were important in in‐flight SARS CoV transmission for different ratios of median dose‐response rate.

The fecal‐oral spread is known to be the primary mode of transmission of norovirus.[5](#ina12445-bib-0005){ref-type="ref"} The fomite route transmission of norovirus is well supported by the reported widespread environmental contamination with norovirus.[36](#ina12445-bib-0036){ref-type="ref"}, [37](#ina12445-bib-0037){ref-type="ref"} Our simulation of a norovirus outbreak confirms that the fomite route is dominant in transmission. It is also suggested that vomiting can produce aerosol droplets containing norovirus particles, and inhaled by exposed susceptible individuals, depositing in the upper respiratory tract and subsequently swallowed along with the respiratory mucus.[38](#ina12445-bib-0038){ref-type="ref"} Airborne norovirus was detected from an air sample in one outbreak.[39](#ina12445-bib-0039){ref-type="ref"} A study of a norovirus outbreak in a hotel found an inverse relationship between the infection risk and the distance from the person who vomited when a food source was not implicated.[40](#ina12445-bib-0040){ref-type="ref"}This study simulated both the airborne and fomite route transmission of norovirus. And the results showed that in most cases, the fomite route plays the dominant role. The predicted infection risk from the fomite route for aisle seat passengers is 2.2 times higher than that for nonaisle seat passengers. The aisle passenger‐to‐non‐aisle passenger relative risk in the outbreak (9.5) is much higher than 2.2, and may be attributable to a small sample size of secondary cases (6).

5. CONCLUSIONS {#ina12445-sec-0015}
==============

In conclusion, a mathematical model was built to simulate the physical process of in‐flight transmission of influenza A H1N1, SARS CoV coronavirus, and norovirus. Our model used the same mechanisms of fomites (a surface contamination network) and bioaerosol transport (ie, close contact and airborne) for all pathogens in similar environment settings (air cabins), with the only differences being in the pathogen‐specific parameters (eg, inactivation rate, surface transfer efficiency). Our simulation results have some aspects that are similar to the outbreak data in terms of the spatial distribution of secondary cases. Although with uncertainties, the simulation results suggested that for in‐flight influenza A H1N1 transmission, the airborne and close contact routes may be much more important than the fomite route; for SARS CoV, although the fomite route is slightly more important than the other routes, it is not dominant and all 3 transmission routes are found to be important; for norovirus transmission, the fomite route may be dominant. Our results reveal that environment control in indoor environments should consider all 3 possible transmission routes for respiratory and enteric infections. Additionally, this study highlights a way to use observation outbreak data to analyze the relative importance of different routes in infection transmission.
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